Notes
In conclusion, we have developed a methodology for
J . Org. Chem., Vol. 67, No. 7, 2002 2377
3-Ben zyloxy-5-(m eth oxyca r bon yl)isoth ia zole (7d ). The
reaction was carried out as described in the general procedure.
The crude product was purified using flash chromatography
(heptane/EtOAc 9:1, Rf ) 0.25) to give 7d as a clear oil (73 mg,
56%): 1H NMR δ 7.50-7.30 (m, 5H), 7.16 (s, 1H), 5.41 (s, 2H),
3.91 (s, 3H); 13C NMR δ 168.59, 160.53, 156.36, 136.13, 128.69,
regioselective generation of the 5-lithio anion of the
3-oxygenated isothiazole heterocycle. To our knowledge,
this is the first report on direct functionalization on this
parental system. The 5-lithio anion of 4 showed high
stability in diethyl ether, whereas in THF decomposition
was progressing over time. A mechanism of decomposi-
tion was suggested based on identification of a degrada-
tion product. We were able to demonstrate the capture
of the 5-lithio anion of 4 with a variety of electrophiles,
which gave the desired products 7a ,b,d -g in 54-68%
isolated yield, whereas attempted benzoylation to give
7c was unsuccessful. The intermediate 7g was depro-
tected in two steps to give thioibotenic acid (1), which
will undergo further pharmacological characterization as
a glutamic acid receptor ligand in our laboratory, and
results will be reported elsewhere.
128.40, 128.22, 115.98, 70.61, 52.66. Anal. Calcd for C12H11
-
NO3S: C, 57.82; H, 4.45; N, 5.62. Found: C, 58.20; H, 4.49; N,
5.64.
3-Ben zyloxy-5-for m ylisot h ia zole (7e). The reaction was
carried out as described in the general procedure. The crude
product was purified on flash chromatography (heptane/EtOAc
9:1, Rf ) 0.2) to give 7e as a light yellow solid (62 mg, 54%): 1H
NMR δ 10.00 (s, 1H), 7.50-7.35 (m, 5H), 7.14 (s, 1H), 5.43 (s,
2H); 13C NMR δ 181.84, 169.06, 163.71, 135.93, 128.70, 128.53,
128.33, 117.09, 70.92. Anal. Calcd for C11H9NO2S: C, 60.26; H,
4.14; N, 6.39. Found: C, 60.03; H, 3.97; N, 6.32.
3-Ben zyloxy-5-(1-h ydr oxycycloh exyl)isoth iazole (7f). The
reaction was carried out as described in the general procedure.
The crude product was purified using flash chromatography
(heptane/EtOAc 4:1, Rf ) 0.25) to give 7f as a clear oil (102 mg,
68%): 1H NMR δ 7.47-7.30 (m, 5H), 6.48 (s, 1H), 5.36 (s, 2H),
2.19 (s, 1H), 1.98-1.58 (m, 10H); 13C NMR δ 179.62, 168.59,
136.65, 128.58, 128.18, 107.44, 72.59, 69.94, 39.34, 24.94, 21.63.
Anal. Calcd for C16H19NO2S: C, 66.40; H, 6.62; N, 4.84. Found:
C, 66.28; H, 6.75; N, 4.65.
Exp er im en ta l Section
All reagents were obtained from commercial suppliers and
used without further purification. THF was distilled from
sodium/benzophenone and Et2O was dried over sodium. NMR
(300 MHz) spectra were recorded in CDCl3 using CHCl3 as
reference. Merck Kieselgel (35-70 mesh) was used for flash
chromatography.
Eth yl 2-ter t-Bu tyloxyca r bon yla m in o-2-eth oxyca r bon yl-
2-(3-ben zyloxy-5-isoth ia zolyl)a ceta te (7g). The reaction was
carried out as described in the general procedure using imine 6
as the electrophile.7 Isolation by flash chromatography (heptane/
EtOAc 4:1, Rf ) 0.25) gave crude 7g as a clear oil (135 mg, 56%),
which was not purified further: 1H NMR δ 7.47-7.30 (m, 5H),
3-(Ben zyloxy)isoth ia zole (4). To a solution of 3-hydroxy-
isothiazole8 (2.02 g, 20 mmol) in DMF (20 mL) at 0 °C was added
K2CO3 (5.53 g, 40 mmol) followed by benzyl bromide (2.74 mL,
23 mmol). The reaction mixture was allowed to stir for 48 h at
rt, diluted with H2O (200 mL), and extracted with Et2O. The
organic layer was washed with brine, dried (Na2SO4), and
evaporated to give a crude product (2:1 O/N mixture based on
1H NMR) that was purified by short column flash chromatog-
raphy (heptane/EtOAc 4:1) followed by submission to high
vacuum for 72 h to give 4 as a clear oil (2.29 g, 60%): 1H NMR
δ 8.46 (d, 1H, J ) 5 Hz), 7.49-7.30 (m, 5H), 6.65 (d, 1H, J ) 5
Hz), 5.42 (s, 2H); 13C NMR δ 169.61, 149.00, 136.66, 128.65,
128.29, 128.25, 112.05, 70.49. Anal. Calcd for C10H9NOS: C,
62.80; H, 4.74; N, 7.32. Found: C, 63.05; H, 4.45; N, 7.17.
Gen er a l P r oced u r e for th e P r ep a r a tion of 5-Su bstitu ted
3-(Ben zyloxy)isoth ia zoles (7a ,b,d -g). To freshly prepared
LDA (0.58 mmol) in Et2O (4.5 mL) at -78 °C under N2 was added
dropwise 3-(benzyloxy)isothiazole (4) (100 mg, 0.52 mmol) dis-
solved in Et2O (0.3 mL). After 15 min, the appropriate electro-
phile (0.58 mmol) dissolved in Et2O (0.2 mL) was added and
stirring continued at -78 °C for 15 min. The reaction mixture
was quenched with saturated NH4Cl and extracted with EtOAc.
The organic layer was washed with brine, dried (Na2SO4), and
evaporated to give the crude products 7a ,b,d -g.
3
1
6.75 (s, 1H), 6.50 (br s,
/ H), 6.30 (br s, / H), 5.35 (s, 2H),
4
4
4.40-4.20 (m, 4H), 1.43 (br s, 9H), 1.26 (t, 6H, J ) 7 Hz).
2-Am in o-2-(3-h yd r oxy-5-isoth ia zolyl)a cetic Acid (1). To
a solution of 7g (1.87 g, 4.02 mmol) in THF (50 mL) at rt was
added LiOH (aq) (50 mL, 2.5 M) and the mixture stirred for 4
h. The reaction mixture was then cooled to 0 °C and the pH
adjusted to 2 with 1 M HCl (aq). The aqueous phase was
extracted with EtOAc, and the collective organic layers were
washed with brine, dried (Na2SO4), and evaporated to give the
crude product. Isolation by flash chromatography (CH2Cl2,
MeOH, AcOH 100:5:2, Rf ) 0.28) gave crude 8 as a clear oil (1.25
g, 76%) that was used without further purification. To a solution
of 8 (1.25 g, 3.06 mmol) in glacial AcOH (15 mL) was added 10%
HBr/AcOH (15 mL), and the reaction mixture was stirred at rt
for 2 h. After evaporation, the crude product was trituated with
Et2O, H2O (20 mL) was added, and the crystals that formed were
filtered off. The crystals were washed with H2O and then dried
to give 1 as a yellow semicrystalline solid (360 mg, 60%):. 1H
NMR (DMSO) δ 9.05 (br s, 3H), 6.84 (s, 1H), 5.62 (br s, 1H); 13
C
NMR (DMSO/-OH) δ 178.84, 176.08, 167.05, 127.45, 113.19.
Recrystallization of a sample from H2O: mp ) 178-180 °C.
Anal. Calcd for C5H6N2O3S: C, 34.48; H, 3.47; N, 16.08. Found:
C, 34.45; H, 3.32; N, 15.80.
3-Ben zyloxy-5-(r-h yd r oxyben zyl)isoth ia zole (7b). The
reaction was carried out as described in the general procedure.
The crude product was purified using flash chromatography
(heptane/EtOAc 4:1, Rf ) 0.25) to give 7b as a white solid (102
mg, 65%): 1H NMR δ 7.45-7.30 (m, 10H), 6.37 (s, 1H), 6.02 (s,
1H), 5.34 (s, 2H); 13C NMR δ 172.70, 168.60, 141.90, 128.97,
128.79, 128.60, 128.25, 128.18, 126.52, 109.49, 71.88, 70,11. Anal.
Calcd for C17H15NO2S: C, 68.66; H, 5.08; N, 4.71. Found: C,
68.46; H, 4.83; N, 4.68.
Ack n ow led gm en t. We would like to thank Dr. Tine
Bryan Steensbøl at the Royal Danish School of Phar-
macy for the preliminary biological testing.
J O0162134